AwesomeCapital

NuVasive Q2 beat propels shares, up 7% after hours

NuVasive (NASDAQ:NUVA) Q2 results ($M): Revenue: 292.1 (+3.7%); product sales: 261.4 (+3.4%).

Net income: 15.0 (+30.4%); non-GAAP net income: 32.8 (+8.3%); EPS: 0.29 (+31.8%); non-GAAP EPS: 0.63 (+8.6%).

Cash flow ops (6 mo.): 93.4 (+21.0%).

2019 guidance: Revenue: $1.14B – 1.16B (unch); EPS: $0.93 – 1.03 from $0.95 – 1.03; non-GAAP EPS: $2.25 – 2.35 from $2.20 – 2.30.

Shares up 7% after hours.

Previously: NuVasive EPS beats by $0.07, beats on revenue (July 30)

https://seekingalpha.com/news/3483711-nuvasive-q2-beat-propels-shares-7-percent-hours

BioTelemetry EPS beats by $0.19, beats on revenue

BioTelemetry (NASDAQ:BEAT): Q2 Non-GAAP EPS of $0.53 beats by $0.19; GAAP EPS of $0.23 misses by $0.11.

Revenue of $111.8M (+10.3% Y/Y) beats by $0.69M.

Press Release

https://seekingalpha.com/news/3483753-biotelemetry-eps-beats-0_19-beats-revenue

Acadia Healthcare EPS beats by $0.02, misses on revenue

Acadia Healthcare (NASDAQ:ACHC): Q2 Non-GAAP EPS of $0.61 beats by $0.02; GAAP EPS of $0.55 misses by $0.05.

Revenue of $789.36M (+3.1% Y/Y) misses by $5.95M.

Press Release

https://seekingalpha.com/news/3483759-acadia-healthcare-eps-beats-0_02-misses-revenue

Bayer nixes plans to sell Monsanto crop product in U.S. next year

Bayer (OTCPK:BAYRY) says it is canceling plans for wide sales next year of a Monsanto chemical that is intended to protect U.S. crops from attacks by certain worms, citing safety concerns.

Bayer says it will not offer the NemaStrike product broadly in 2020 for corn, cotton or soybeans after reviewing the experiences farmers and applicators had with it this year.

Monsanto had held off on plans to launch NemaStrike across as many as 8M U.S. crop acres in 2018, following reports that it caused rashes; the company had called the product a “blockbuster” and said at the time that it could be used safely when users follow label instructions.

The decision is the latest setback for Bayer following its $63B acquisition of Monsanto last year; Bayer is battling thousands of lawsuits claiming Monsanto’s Roundup weedkiller causes cancer.

https://seekingalpha.com/news/3483775-bayer-nixes-plans-sell-monsanto-crop-product-u-s-next-year